Topiderm, Inc.
FDA inspection history in North Amityville, New York, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483, at North Amityville, New York.
Cited most
Across all Topiderm observations on file
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures3
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.192Production record review1
The complete Topiderm file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
North Amityville, New York
One Form 483 · 2025 · 8 observations
Latest: Form 483, Mar 7, 2025 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-03-07 | 483 Form 483 | North Amityville, New York | 8 | $99 |
Investigators on these documents
FEI number 2432734 · most recent document Mar 7, 2025
About Topiderm, Inc.
How many FDA Form 483s has Topiderm, Inc. received?
FDA Intel has 1 Form 483 on file for Topiderm, Inc.; the most recent is dated Mar 7, 2025.
When was Topiderm, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Topiderm, Inc. is a Form 483 dated Mar 7, 2025, for the site in North Amityville, New York.
What did FDA cite at Topiderm, Inc.?
The regulations cited most in the observations on file for Topiderm, Inc. are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 3 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.